The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial
Open accessAbstract
Background: This randomized controlled study sought to determine the effect of intermittent fasting on anthropometric measurements, fibroblast growth factor (FGF)-21, and autophagy markers, as well as on hepatic steatosis and fibrosis levels in overweight or obese patients with metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: Patients were randomly assigned into two groups: received a dietary treatment involving 22–25 kcal/kg/day of energy for 8 weeks and followed the same dietary intervention and a 16:8 pattern. The extent of hepatic steatosis and fibrosis was determined using transient elastography on a FibroScan® device. The controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), determined by transient elastography, reflect hepatic steatosis and fibrosis, respectively. In duplicate, serum levels of FGF-21, Beclin-1, and ATG-5 were determined using enzyme-linked immunosorbent assay. Results: The study included 48 patients with a mean age of 48.2 ± 1.4 years (27 female and 21 male). Improvements in anthropometric measurement and CAP and LSM levels and a decrease in serum FGF-21 levels were found in both groups (p < 0.05). Changes in the CAP and FGF-21 levels were higher in the energy + time-restricted diet group (p < 0.05). Autophagy-related protein (ATG)-5 levels increased only in the energy + time-restricted diet group [(0.74 (0.46–1.29) ng/mL vs. 0.95 (0.73–1.32) ng/mL, p = 0.03]. Conclusions: Intermittent fasting was potentially practical in the management of MAFLD. In particular, changes in FGF-21 and ATG-5 levels indicate the potential of intermittent fasting to regulate metabolic processes and autophagy. However, methodological limitations should be taken into consideration when interpreting the study results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Seven trials found no significant between-group differences in energy intake during the intervention (21, 24, 25), in change from baseline (16, 18, 25), or in post-intervention energy intake (20, 22), whereas two studies reported lower caloric intake in the IF groups than in the CER groups (23, 24).”
From Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis (2026) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Eight trials employed a parallel-group design (16, 18–24), and one utilized a crossover design (25).”
From Intermittent fasting versus continuous energy restriction in MASLD: a systematic review and meta-analysis (2026) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · cited 2×
“The diets The diets were planned based on current guidelines, manuals, systematic reviews, and meta-analyses published in recent years on MAFLD [6,7,31]. were planned based on current guidelines, manuals, systematic reviews, and meta-analyses published in recent years on MAFLD [6,7,31].”
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472 · cited 2×
“…type 2 diabetes mellitus (T2DM), or underweight or normal weight with at least two metabolic risk abnormalities [waist circumference, blood pressure, triglycerides, high-density lipoprotein cholesterol (HDL-C), prediabetes, insulin resistance, high-sensitivity C reactive protein (CRP)] [29].”
Self-citationFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125 · cited 2×
“Endogenous FGF-21 has been shown to facilitate insulin-independent glucose uptake in adipocytes and promote lipolysis, which reduces fat storage [25,26].”
Hatori, M., Vollmers, C., Zarrinpar, A., DiTacchio, L., Bushong, E. A., Gill, S., Leblanc, M., Chaix, A., Joens, M., Fitzpatrick, J. A. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.019 · Cited by 1,986 · cited 1×
“Thus, the intermittent fasting protocol has been hypothesized to be a potentially effective intervention in MAFLD [13–15].”
Sutton, E. F., Beyl, R., Early, K. S., Cefalu, W. T., Ravussin, E., & Peterson, C. M. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.010 · Cited by 1,531 · cited 1×
“This pattern can positively affect metabolic health by supporting circadian rhythm [9].”
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504 · cited 1×
“Endogenous FGF-21 has been shown to facilitate insulin-independent glucose uptake in adipocytes and promote lipolysis, which reduces fat storage [25,26].”
Impact of intermittent fasting on health and disease processes
Mattson, M. P., Longo, V. D., & Harvie, M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.005 · Cited by 1,187 · cited 1×
“One of the mechanisms by which intermittent fasting counteracts disease processes is the activation of cellular stress response signaling pathways that stimulate autophagy [16].”
TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
Settembre, C., De Cegli, R., Mansueto, G., Saha, P. K., Vetrini, F., Visvikis, O., Huynh, T., Carissimo, A., Palmer, D., Jürgen Klisch, T., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2718 · Cited by 1,022 · cited 1×
“In recent years, increasing evidence suggests that autophagy is regulated during eating– starving cycles under physiological conditions [17,18].”
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908 · cited 1×
“In clinical studies, elevated serum levels of FGF-21 have been associated with obesity, metabolic syndrome, and diabetes [23], which are components of MAFLD.”
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 683
Cited by
Non-pharmacological treatment of MASLD
Dufour, J., & Berzigotti, A. (2026) · Diabetologia · doi:10.1007/s00125-026-06811-5 · Cited by 1
Li, H., & Li, T. (2026) · Frontiers in nutrition · doi:10.3389/fnut.2026.1833688 · Cited by 1
Alqahtani, H. A., & Aref, M. (2025) · Arab Journal of Basic and Applied Sciences · doi:10.1080/25765299.2025.2553434
“IF was potentially practical in the management of hepatic steatosis, inflammation, or fibrosis in fatty liver disease associated with metabolic dysfunction via reduction of fibroblast growth factor levels, regulation of metabolic processes and autophagy (Ozlu Karahan et al., 2025).”
Structural and Functional Characterization of the Mouse Liver during Intermittent Fasting
Dmitrieva, S. A., Giniyatullina, D. M., Vologin, D. S., & Ponomareva, A. A. (2026) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093026020079
Advances in Non-Alcoholic Fatty Liver Disease: Pathophysiology, Diagnosis, and Emerging Therapies
Katsaros, I., & Schizas, D. (2026) · Life · doi:10.3390/life16060915
“Whether examined through the lens of IBD-associated intestinal permeability, [4,5], the autophagic responses modulated by fasting cycles [6], or the microbial signatures associated with fibrosis and genetic susceptibility [8], dysbiosis and its downstream hep-atic consequences appear critical to…”
Metadata
- Authors
- Ozlu Karahan, T., Yilmaz Akyuz, E., Yilmaz Karadag, D., Yilmaz, Y., & Eren, F.
- Affiliations
- Department of Nutrition and Dietetics, Faculty of Health Sciences, Istanbul Bilgi University, Istanbul 34440, Turkey
- Department of Nutrition and Dietetics, Hamidiye Faculty of Health Sciences, University of Health Sciences, Istanbul 34668, Turkey
- Institute of Gastroenterology, Marmara University, Istanbul 34854, Turkey
- Recep Tayyip Erdoğan University (TR)
- Corresponding author
- Eren, Fatih
- Venue
- Life
- Publisher
- MDPI AG
- Published
- 2025-04-25
- Volume
- 15
- Issue
- 5
- Pages
- 696
- ISSN
- 2075-1729 (ISSN-L)
- PMC
- PMC12113254
- OpenAlex
- W4409781467
- Cited by
- 9
- References
- 69
- Citations by year
- 2026: 8 · 2025: 1
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Life (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Health Institutes of Türkiye (TUSEB) (24172, 02025002003275)
- Recep Tayyip Erdoğan University Development Foundation (24172, 02025002003275)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- intermittent fasting, non-alcoholic fatty liver disease, hepatic steatosis, liver fibrosis, FGF21, autophagy, ATG5, Beclin-1, time-restricted eating, hypocaloric diet, obesity, transient elastography, controlled attenuation parameter, liver stiffness measurement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.3390/life15050696
- The paper
- Ozlu Karahan, T., Yilmaz Akyuz, E., Yilmaz Karadag, D., Yilmaz, Y., & Eren, F. (2025). Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. Life. https://doi.org/10.3390/life15050696
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.